OP13.01: *Effective aspirin treatment for women at risk of pre‐eclampsia delays the metabolic clock of gestation

Documenti analoghi

• OC01.02: *Effect of aspirin on placental biomarkers profile in high‐risk women for pre‐eclampsia
  di: L. Nguyen Hoang, et al.
  Pubblicazione: (2024)
• Assessment of risk for pre‐eclampsia at mid‐gestation to define subsequent care
  di: S. Adjahou, et al.
  Pubblicazione: (2025)
• Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
  di: N. Sokratous, et al.
  Pubblicazione: (2024)
• OP13.05: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse maternal outcome in women with suspected pre‐eclampsia
  di: Y. Wah, et al.
  Pubblicazione: (2024)
• Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study
  di: X. Wang, et al.
  Pubblicazione: (2025)